Skip to main content

New Business Development VP Karen Josey Will Build Awareness of Clinical Educators to Improve Patient Compliance as VMS BioMarketing Moves Into Phase II-IV Clinical Trial Space



INDIANAPOLIS - January 16, 2019 - (Newswire.com)

VMS BioMarketing has announced the appointment of Karen M. Josey to the position of Vice President, Business Development. In this role, Josey will advance new business opportunities in the pharmaceutical and biotech industry, helping new clients develop education and adherence programs. She will have a particular focus within the clinical trial space to develop personalized solutions for trial subjects and site staff leveraging Clinical Trial Educators to improve protocol compliance and enhance the patient experience.

VMS President and CEO Andrea Heslin Smiley said, “We welcome Karen Josey to our team. This appointment will continue to strengthen VMS BioMarketing as a leading global player in patient support and education throughout the product lifecycle, expand our therapeutic expertise and extend our capacity to help current and future clients deliver compliant and patient-centric clinical trials.”

Josey brings to this role 30 years of marketing experience in the health care and pharmaceutical industry working at contract research organizations (CROs), medical staffing companies, pharma manufacturers, and health care provider organizations.

“At the heart of my work in the health care field has been the needs and advocacy for the patient,” said Josey. “I am so excited to be a part of the VMS team where personalizing the patient’s journey with the services of Clinical Educators is our primary focus.”

Most recently, Josey worked in the CRO industry at companies providing clinical trial services to pharmaceutical, biotech, and medical device companies. She designed, developed and implemented comprehensive strategic business development programs and worked closely with clients to identify and articulate value drivers that align with clinical and operational objectives. Josey has been responsible for building and expanding relationships with customers across the globe to bring innovations such as direct-to-patient home visits within phase I-V clinical trials.

In addition, Josey has extensive experience in the medical staffing field, having been responsible for the hiring and training of more than 250 per diem and travel nurses to support the operations of multiple large national contracts.

“I am looking forward to using my experience and resources in the pharmaceutical and CRO industry to help VMS develop customized, patient-centric solutions that build awareness and brand loyalty in the clinical trial space,” said Josey.

Josey is a graduate of the University of Michigan with both the Master of Business Administration and Bachelor of Business Administration degrees. She is the recipient of numerous sales and marketing awards throughout her career, and she served as President of the Board of Directors for the Cystic Fibrosis Foundation.

About VMS BioMarketing: 
VMS BioMarketing is a leading provider of patient support solutions focused on empowering patients and health care providers through education, training, and ongoing health coaching. For more than 20 years, VMS has been dedicated to enabling Clinical Educators to provide the personalized support necessary to help patients successfully start and stay on therapy. VMS clients include the world’s leading pharmaceutical and biotechnology companies. To learn more, please visit www.vmsbiomarketing.com.

Contact: Abigail Mallon
317-805-6600, Ext. 225
Abigail.Mallon@vmsbiomarketing.com




Press Release Service by Newswire.com

Original Source: New Business Development VP Karen Josey Will Build Awareness of Clinical Educators to Improve Patient Compliance as VMS BioMarketing Moves Into Phase II-IV Clinical Trial Space
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.